FDA Reveals Criteria For Importing Unapproved Drugs
The draft document concerns so-called Pre-Launch Activities Importation Requests, or PLAIRs, that manufacturers of branded and generic drugs submit shortly before they expect to receive FDA approval to sell their products. Nearly 200 such applications are expected annually from about 50 different drugmakers, the agency projects.
Federal law ostensibly bars...
To view the full article, register now.